Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people. (2009)

First Author: MRC/BHF Heart Protection Study Collaborative Group
Attributed to:  CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/1472-6904-9-6

PubMed Identifier: 19442259

Publication URI: http://europepmc.org/abstract/MED/19442259

Type: Journal Article/Review

Volume: 9

Parent Publication: BMC clinical pharmacology

ISSN: 1472-6904